ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1648

PD-1+CD45RBlo122lo Autoantibody-Inducing CD4 T Cells (aiCD4 T cells) As a Key In The Pathogenesis Of Systemic Lupus Erythematosus (SLE)

Yumi Miyazaki1, Ken Tsumiyama2 and Shunichi Shiozawa1, 1Department of Medicine, Kyushu University Beppu Hospital, Beppu, Japan, 2Department of Rheumatology, Kyushu University Beppu Hospital, Beppu, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: anti-dsDNA, autoantibodies and systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Email
  • Print
Session Information

Title: T-cell Biology in Autoimmune Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:  We found that systemic lupus erythematosus (SLE) was induced experimentally by repeatedly immunizing the mice normally not prone to autoimmune diseases by any exogenous antigen so far examined (Tsumiyama K. et al. PLoS ONE 4(12):e8382, 2009). We have then proposed a novel ‘self-organized criticality theory’ that takes place when host’s immune system is overstimulated by repeated exposure to antigen to levels that surpass the immune system’s stability limit, i.e., self-organized criticality. The autoreactive lymphocyte clones, which we name autoantibody-inducing CD4 T cells (aiCD4 T cells), are newly generated via de novo T cell receptor (TCR) revision from thymus-passed non-autoreactive clones at peripheral lymphoid organs. They not only stimulated B cells to generate varieties of autoantibodies but also helped final differentiation of CD8 T cell into cytotoxic T lymphocyte (CTL) via antigen cross-presentation to induce tissue injuries identical to SLE. We further showed that the transfer of CD45RBlo122lo CD4 T cell of repeatedly-immunized mice could did induce autoantibodies in the naïve recipients, indicating that aiCD4 T cell seemed to belong to CD45RBlo122lo CD4 T subpopulation. To identify the phenotype of aiCD4 T cell in more detail, we here performed microarray analysis and cell transfer assay to show that aiCD4 T cell belongs to PD-1+CD45RBlo122loCD4 subpopulation.

Methods:  BALB/c mice were repeatedly immunized with ovalbumin (OVA). To investigate gene expression profiles of aiCD4 T cell, we performed microarray analysis (Whole Mouse Genome Microarray; Agilent Technologies) of CD45RBlo122lo CD4 T cell after immunization 12x with OVA. We also studied protein expression on CD45RBlo122lo CD4 T cell by flow cytometric analysis. CD45RBlo122loCD4 T cells were isolated additionally referring to PD-1 expression, and these fractionated cells were adoptively transferred into naïve recipients. Autoantibodies in sera of recipient mice were measured 2 weeks after cell transfer.

Results: Upon repeated immunization 12x with OVA, varieties of autoantibodies including RF, anti-Sm and anti-dsDNA antibodies were generated. Under microarray analysis, we compared the gene expression profile between CD45RBlo122lo CD4 T cell and the rest of CD4 T cell subsets after immunization 12x with OVA. We found that gene expression of programmed cell death 1 (PD-1) was increased x2 in the CD45RBlo122lo CD4 subset. Simultaneously, surface expression of PD-1 protein was also significantly increased in this subset: The PD-1+ cell was concentrated up to 25.2 ± 6.3% in CD45RBlo122lo CD4 T subset versus 7.5 ± 2.4% in CD45RBhi and/or CD122hi CD4 T subset (P < 0.001). Adoptive cell transfer from 12x immunized mice showed that RF and anti-dsDNA antibody in the transferred recipients with PD-1+CD45RBlo122lo CD4 T cell were 36.3 ± 336.0 U/ml and 0.5 ± 0.007 AU, whereas those with PD-1–CD45RBlo122lo CD4 T cell were 12.6 ± 2.9 U/ml and 0.4 ± 0.002 AU, respectively (P < 0.05 and P < 0.05). These results indicated that PD-1+CD45RBlo122loCD4 T cells were capable of inducing autoantibodies in the naïve recipients.

Conclusion: The aiCD4 T cell that induces SLE belongs to a PD-1+CD45RBlo122lo CD4 subpopulation.


Disclosure:

Y. Miyazaki,
None;

K. Tsumiyama,
None;

S. Shiozawa,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pd-1cd45rblo122lo-autoantibody-inducing-cd4-t-cells-aicd4-t-cells-as-a-key-in-the-pathogenesis-of-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology